BioSig Technologies, Inc. announced that it has entered into a Securities Purchase Agreement with certain accredited investors to issue an aggregate of 990,954 common shares, par value $0.001 per share at a purchase price of $0.55502 per share, and warrants to purchase up to 495,477 shares of common stock at an exercise price of $0.49252 per share, that will become exercisable six months after the date of issuance and will expire five and one-half years following the date of issuance, in exchange for aggregate gross proceeds of $549,999.29 on September 12, 2023. The Securities were offered and sold in reliance on the exemption from registration under the Securities Act of 1933, as amended and provided by Section 4(a)(2) and Regulation D (Rule 506) under the Securities Act.